UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
August 17, 2001
---------------
PROXYMED, INC.
--------------
(Exact name of registrant as specified in its charter)
Florida 000-22052 65-0202059
------- --------- ----------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
2555 Davie Road, Suite 110, Ft. Lauderdale, Florida 33317-7424
--------------------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (954) 473-1001
---------------
Item 5. Other Events.
On August 17, 2001, the Company filed a press release announcing its
completion of an exchange of warrants issued in connection with its Series C
preferred stock by exchanging 21.1 million warrants for 15.7 million shares of
common stock. In addition to the warrant exchange, the Company announced a
1-for-15 reverse stock split of its common stock whereby each 15 shares of
common stock would be exchanged for one new share of common stock (see Exhibit
99.1).
Item 7. Exhibits.
(c) The following exhibits are included herein:
Exhibit 2.1 - Articles of Amendment to Articles of Incorporation
dated July 25, 2001, increasing the authorized
shares of common stock to 200,000,000, par value
$.001.
Exhibit 2.2 Articles of Amendment to Articles of Incorporation
dated August 21, 2001, authorizing the 1-15 reverse
stock split.
Exhibit 99.1 Press Release dated August 17, 2001, reporting the
completion of an exchange of warrants issued in
connection with its Series C preferred stock and
the Company's 1-15 reverse stock split.
1
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ProxyMed, Inc.
Date: August 21, 2001 /s/ Judson E. Schmid
--------------- ------------------------------------
Judson E. Schmid, Executive Vice
President and Chief Financial Officer
2
INDEX TO EXHIBITS
EXHIBIT NUMBER DESCRIPTION
-------------- -----------
2.1 Articles of Amendment to Articles of
Incorporation dated July 25, 2001,
increasing the authorized shares of common
stock to 200,000,000, par value $.001.
2.2 Articles of Amendment to Articles of
Incorporation dated August 21, 2001,
authorizing the 1-15 reverse stock split.
99.1 Press Released dated August 17, 2001,
reporting the completion of an exchange of
warrants issued in connection with its
Series C preferred stock and the Company's
1-15 reverse stock split.
3